Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen (Q40428119)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

0 references

Lactococcus lactis

object named as

Lactococcus lactis

1 reference

based on heuristic

inferred from title

author name string

Adrian C N Sim

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Wenwei Lin

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Grace K X Tan

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Magenta S T Sim

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Vincent T K Chow

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sylvie Alonso

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

0 references

publication date

18 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1145-1154

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Yellow fever vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Japanese encephalitis and dengue vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Current status of flavivirus vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Traditional and novel approaches to flavivirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Development of new vaccines against dengue fever and Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

The future of dengue vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Liver injury and viremia in mice infected with dengue-2 virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Development of a novel mouse model for dengue virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

A Dengue Fever Viremia Model in Mice Shows Reduction in Viral Replication and Suppression of the Inflammatory Response after Treatment with Antiviral Drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Studies on the glycosylation of flavivirus E proteins and the role of carbohydrate in antigenic structure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Flavivirus genome organization, expression, and replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Correlation of E protein binding with cell susceptibility to dengue 4 virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Membrane interactions of the tick-borne encephalitis virus fusion protein E at low pH.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Synergistic Interactions of Anti-NS1 Monoclonal Antibodies Protect Passively Immunized Mice from Lethal Challenge with Dengue 2 Virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Characterization of Antibody Responses to Combinations of a Dengue Virus Type 2 DNA Vaccine and Two Dengue Virus Type 2 Protein Vaccines in Rhesus Macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

A ligand-binding pocket in the dengue virus envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Induction of neutralizing antibodies and T cell responses by dengue virus type 2 envelope domain III encoded by plasmid and adenoviral vectors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Pharmacokinetics of Lactobacillus plantarum NCIMB 8826, Lactobacillus fermentum KLD, and Lactococcus lactis MG 1363 in the human gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Production and targeting of the Brucella abortus antigen L7/L12 in Lactococcus lactis: a first step towards food-grade live vaccines against brucellosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Rotavirus vp7 antigen produced by Lactococcus lactis induces neutralizing antibodies in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Oral vaccination of mice against rodent malaria with recombinant Lactococcus lactis expressing MSP-1(19).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Intranasal immunisation with recombinant Lactococcus lactis displaying either anchored or secreted forms of Proteus mirabilis MrpA fimbrial protein confers specific immune response and induces a significant reduction of kidney bacterial colonisation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Protective immunity of SpaA-antigen producing Lactococcus lactis against Erysipelothrix rhusiopathiae infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Efficient plasmid mobilization by pIP501 in Lactococcus lactis subsp. lactis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Differential dengue cross-reactive and neutralizing antibody responses in BALB/c and Swiss albino mice induced by immunization with flaviviral vaccines and by infection with homotypic dengue-2 virus strains.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

The immune response to Lactococcus lactis: implications for its use as a vaccine delivery vehicle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Optimism over vaccines administered via mucosal surfaces.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

A fusogenic peptide expressed on the surface of Salmonella enterica elicits CTL responses to a dengue virus epitope.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Use of live bacterial vaccine vectors for antigen delivery: potential and limitations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

On the safety of lactic acid bacteria from food

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Potential and opportunities for use of recombinant lactic acid bacteria in human health

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Ability of Lactococcus lactis to export viral capsid antigens: a crucial step for development of live vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Expression of Helicobacter pylori cag12 gene in Lactococcus lactis MG1363 and its oral administration to induce systemic anti-Cag12 immune response in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Analysis of C-terminally truncated dengue 2 and dengue 3 virus envelope glycoproteins: processing in insect cells and immunogenic properties in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Induction of tetravalent protective immunity against four dengue serotypes by the tandem domain III of the envelope protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

Demonstration of binding of dengue virus envelope protein to target cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

PrM- and cell-binding domains of the dengue virus E protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

based on heuristic

inferred from DOI database lookup

Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasmid complements of Streptococcus lactis NCDO 712 and other lactic streptococci after protoplast-induced curing.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

based on heuristic

inferred from DOI database lookup

Particulate systems as adjuvants and carriers for peptide and protein antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

based on heuristic

inferred from DOI database lookup

Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

based on heuristic

inferred from DOI database lookup

Murine immunoglobulin G subclass responses following immunization with live dengue virus or a recombinant dengue envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.047

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.12.047

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40428119&oldid=1897731256"